Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)

Global Phase 3 INDIGO study will evaluate the efficacy and safety of obexelimab in patients with IgG4-RD, a chronic and serious fibroinflammatory disease typically affecting multiple organs IgG4-RD is the first of several potential disease indications to be pursued for obexelimab given its unique non-depleting, B-cell inhibition WALTHAM, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) — […]

Africa CDC Headquarters Building Project First Phase Inaugurated

The headquarters of the Africa Centers for Disease Control and Prevention (Africa CDC) was Inaugurated today in the presence of Chinese Foreign Minister, Qin Gang and Chairperson of the African Union Commission, Moussa Faki Mahamat.The inauguration cer…

Ethiopia to Export Meat to China, Indonesia

Ethiopia is undertaking preparations to export meat to China and Indonesia markets, according to Agriculture Authority.Export Abattoir Supervision and License at Agriculture Authority, Ayalew Shumet told ENA that Ethiopia’s current meat export stands a…